Mesalamine Tablet, Delayed Release
Product Images NDC 70771-1071

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 70771-1071). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0597b64c Aa1f 42bd 8fc0 49fb44ca0124 02

This is a description of a medication called "Mesalamine". It is available in the form of delayed-release tablets with each tablet containing 12 mg of Mesalamine. The package insert should be consulted for the usual dosage. The tablets should be stored at a temperature between 20 to 25°C and in a light-resistant container as per USP guidelines. The medication should be kept out of the reach of children. The manufacturer of the medication is Zydus.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.